Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Bio-Rad Laboratories, Inc. (BIO) had Cost of Goods Sold of $1.24B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.58B |
|
$759.90M |
|
|
Cost of Goods Sold |
$1.24B |
$1.34B |
|
$2.54B |
|
$47.20M |
|
$948.30M |
|
$995.50M |
|
$95.10M |
|
$759.90M |
|
$759.90M |
|
$759.90M |
|
$-353.59M |
|
$47.20M |
|
$212.60M |
|
27.26M |
|
27.28M |
|
$27.87 |
|
$27.85 |
|
| Balance Sheet Financials | |
$2.91B |
|
$539.90M |
|
$7.67B |
|
$10.58B |
|
$517.00M |
|
$1.20B |
|
$2.61B |
|
$3.12B |
|
-- |
|
$6.70B |
|
$7.45B |
|
-- |
|
| Cash Flow Statement Financials | |
$532.20M |
|
$-189.70M |
|
$-283.20M |
|
$489.80M |
|
$532.20M |
|
$42.40M |
|
$58.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|